Zamiyol Gel
Calcipotriol 52.2μg · Betamethasone Dipropionate 0.643mg
Prescription medication · Combination
Leopharma Co., Ltd.
MFDS item code 201002062 · Approved 2010.03.12 · Insurance code 626700041
Treatment of moderate to severe scalp psoriasis and plaque psoriasis affecting areas other than the scalp
This medication is intended for adolescents aged 12 and older and adults for the topical treatment of moderate to severe scalp psoriasis and plaque psoriasis occurring on areas other than the scalp.
Apply this medicine to the affected area once daily. Use is recommended for 4 weeks on the scalp and 8 weeks on areas other than the scalp. After this period, it may be used repeatedly under a doctor's supervision. The amount used per day must not exceed 15 g, and the maximum amount used per week must not exceed 100 g in adults. The body surface area to which calcipotriol in this medicine is applied must not exceed 30 %. When used on the scalp, apply this medicine to the entire affected area. Usually, 1 g to 4 g per day is sufficient for the scalp (4 g is equivalent to 1 teaspoon). This medicine must not be applied directly to the face or eyes. To achieve the best effect, it is not recommended to shower or wash the hair immediately after applying this medicine. This medicine should remain on the skin overnight or during the day. Shake the bottle before use. Wash your hands after use.
Adolescents: The maximum amount used per week must not exceed 60g.
This medication should not be used in certain patients. For example, patients who have had an allergic reaction or hypersensitivity to this medication or its components, patients with calcium metabolism issues, certain types of psoriasis patients, patients with severe kidney or liver disease, children, and patients using it on the face or around the eyes, or those with eczema that has perforated eardrums should not use this treatment. Also, patients with skin infections due to bacteria, fungi, viruses, parasites, wounds, ulcers, burns, certain dermatitis, acne, and genital itching should not use this medication. Women who are pregnant or of childbearing age, lactating mothers, the elderly, and patients with liver dysfunction or diabetes should use this medication with caution. This medication may cause various side effects such as itching, rash, skin irritation, dryness, skin infections, and rarely may lead to elevated calcium levels in the blood or immune hypersensitivity reactions. Particularly with long-term use or use over large areas, systemic side effects can occur, so caution is needed during use. This medication should not be applied to the face, around the eyes, around the mouth, genital skin, and mucous membrane areas, and hands should be thoroughly washed after use. Moreover, it is advised to avoid excessive exposure to natural or artificial light while using this medication and to discontinue use as soon as symptoms improve. It is preferable not to combine this medication with other corticosteroids or salicylic acid, and pregnant or breastfeeding women should consult a physician before use. While the safety and efficacy of this medication have been partially confirmed for children and adolescents, it is not recommended for children under 12 years of age. In cases of overdose, significant side effects such as elevated blood calcium levels or adrenal suppression may occur, so the prescribed dosage and amount must be strictly followed. Finally, this medication should be stored out of reach of children and used within six months after opening, stored away from light and not refrigerated.
Itching, skin infection, folliculitis, hypersensitivity, eye irritation, exacerbation of psoriasis, dermatitis, erythema, rash, acne, skin burning sensation, skin irritation, skin dryness, skin glands, exfoliation, pain at the site of application, rebound effect, hyperparathyroidism, decrease in blood cortisol, decrease in blood calcium, increase in blood parathyroid hormone, decrease in urine calcium, headache, acneiform dermatitis, itching at the site of application, pustules, pain, fever, redness, allergic contact dermatitis, heat rash, worsening of wounds, pressure sores, pustular psoriasis, angioedema, facial swelling, steroid-induced acne, skin atrophy, telangiectasia, purpura, steroid-induced injection, perioral dermatitis, childhood-like skin changes, hirsutism, loss of pigmentation, increased intraocular pressure, glaucoma, blurred vision, hypercalcemia, severe adrenal cortex dysfunction, cataract, infection, metabolic effects of diabetes, pigmentation changes at the site of application, boils, purpuric spots, petechiae, photosensitivity, steroid skin, local steroid withdrawal syndrome, polyuria, constipation, muscle weakness, confusion, coma, Cushing's syndrome, pustular psoriasis
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in containers that block light. Additionally, it is important to keep it in an airtight container that does not allow air to pass through. The storage temperature should be kept at room temperature between 9 degrees and 30 degrees Celsius.
This medication is a colorless to whitish, nearly transparent lipophilic gel. A thin oily layer may appear on the top.
Bottle - 60 grams/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Calcipotriol 52.2μg · Betamethasone Dipropionate 0.643mg
Prescription medication · Combination
Leopharma Co., Ltd.
Calcipotriol 52.2μg · Betamethasone Dipropionate 0.643mg
Ointment · Prescription medication · Combination
Leo Pharma Co., Ltd.
Calcipotriol Hydrate 52.2μg · Betamethasone Dipropionate 0.643mg
Ointment · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Calcipotriol Monohydrate 52.2μg · Betamethasone Dipropionate 0.643mg
Prescription medication · Combination
JW Pharmaceutical Co., Ltd.
Calcipotriol Monohydrate 52.2μg · Betamethasone Dipropionate 0.643mg
Prescription medication · Combination
Genewon Science Co., Ltd.
Calcipotriol Monohydrate 52.2μg · Betamethasone Dipropionate 0.643mg
Ointment · Prescription medication · Combination
Genewon Science Co., Ltd.
Calcipotriol Hydrate 52.2μg · Betamethasone Dipropionate 0.643mg
Ointment · Prescription medication · Combination
(Co., Ltd.) Telcon RF Pharmaceuticals
Calcipotriol Hydrate 52.2μg · Betamethasone Dipropionate 0.643mg
Ointment · Prescription medication · Combination
Sama Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.